Xu H - Search Results

1

Gross Hematuria Does not Affect the Selection of Nephrectomy Types for Clinical Stage 1 Clear Cell Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study.

Xing Z, Xu H, Ai K, Deng H, Hong Y, Deng P, Wang J, Xiong W, Li Z, Zhu L, Li Y. Xing Z, et al. Among authors: xu h. Ann Surg Oncol. 2024 May;31(5):3531-3543. doi: 10.1245/s10434-024-14958-x. Epub 2024 Feb 8. Ann Surg Oncol. 2024. PMID: 38329657

2

Impact of enhanced recovery after surgery or fast track surgery pathways in minimally invasive radical prostatectomy: a systematic review and meta-analysis.

Lv Z, Cai Y, Jiang H, Yang C, Tang C, Xu H, Li Z, Fan B, Li Y. Lv Z, et al. Among authors: xu h. Transl Androl Urol. 2020 Jun;9(3):1037-1052. doi: 10.21037/tau-19-884. Transl Androl Urol. 2020. PMID: 32676388 Free PMC article.

3

LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis.

Tang C, Cai Y, Jiang H, Lv Z, Yang C, Xu H, Li Z, Li Y. Tang C, et al. Among authors: xu h. Aging (Albany NY). 2020 Nov 20;12(24):25547-25563. doi: 10.18632/aging.104162. Epub 2020 Nov 20. Aging (Albany NY). 2020. PMID: 33231563 Free PMC article.

4

Decreased interferon regulatory factor 6 expression due to DNA hypermethylation predicts an unfavorable prognosis in clear cell renal cell carcinoma.

Li Z, Yang W, Qiu J, Xu H, Fan B, Li K, Zhou J, Li Y. Li Z, et al. Among authors: xu h. J Cancer. 2021 Sep 13;12(22):6640-6655. doi: 10.7150/jca.62394. eCollection 2021. J Cancer. 2021. PMID: 34659554 Free PMC article.

5

Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer.

Lv Z, Wang J, Wang X, Mo M, Tang G, Xu H, Wang J, Li Y, Liu M. Lv Z, et al. Among authors: xu h. Front Cell Dev Biol. 2021 Oct 29;9:666025. doi: 10.3389/fcell.2021.666025. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34778244 Free PMC article.

6

Epigenetic Regulation in Urothelial Carcinoma.

Li K, Qi L, Tang G, Xu H, Li Z, Fan B, Li Z, Li Y. Li K, et al. Among authors: xu h. Curr Mol Med. 2024;24(1):85-97. doi: 10.2174/1566524023666221221094432. Curr Mol Med. 2024. PMID: 36545729 Review.

7

FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway.

Lv Z, Wang M, Hou H, Tang G, Xu H, Wang X, Li Y, Wang J, Liu M. Lv Z, et al. Among authors: xu h. Int J Biol Sci. 2023 Jun 26;19(11):3293-3306. doi: 10.7150/ijbs.84067. eCollection 2023. Int J Biol Sci. 2023. PMID: 37496990 Free PMC article.

8

A Hybrid Nanoadjuvant Simultaneously Depresses PD-L1/TGF-β1 and Activates cGAS-STING Pathway to Overcome Radio-Immunotherapy Resistance.

Yi L, Jiang X, Zhou Z, Xiong W, Xue F, Liu Y, Xu H, Fan B, Li Y, Shen J. Yi L, et al. Among authors: xu h. Adv Mater. 2024 Apr;36(15):e2304328. doi: 10.1002/adma.202304328. Epub 2024 Jan 22. Adv Mater. 2024. PMID: 38229577

9

Patients with high nuclear grade pT1-ccRCC are more suitable for radical nephrectomy than partial nephrectomy: a multicenter retrospective study using propensity score.

Xu H, Xing Z, Ai K, Wang J, Lv Z, Deng H, Li K, Wang Y, Li Y. Xu H, et al. World J Surg Oncol. 2024 Jan 23;22(1):24. doi: 10.1186/s12957-024-03302-y. World J Surg Oncol. 2024. PMID: 38254091 Free PMC article.

10

Identification of molecular subtypes and diagnostic model in clear cell renal cell carcinoma based on collagen-related genes may predict the response of immunotherapy.

Hong Y, Lv Z, Xing Z, Xu H, Chand H, Wang J, Li Y. Hong Y, et al. Among authors: xu h. Front Pharmacol. 2024 Feb 5;15:1325447. doi: 10.3389/fphar.2024.1325447. eCollection 2024. Front Pharmacol. 2024. PMID: 38375034 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,645 results

Search Page

Filters